Cargando…
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Vasoactive Intestinal Peptide (VIP) are neuropeptides involved in a diverse array of physiological and pathological processes through activating the PACAP subfamily of class B1 G protein-coupled receptors (GPCRs): VIP receptor 1 (VPAC1R), VI...
Autores principales: | Lu, Jessica, Piper, Sarah J., Zhao, Peishen, Miller, Laurence J., Wootten, Denise, Sexton, Patrick M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331257/ https://www.ncbi.nlm.nih.gov/pubmed/35897648 http://dx.doi.org/10.3390/ijms23158069 |
Ejemplares similares
-
Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021) -
PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023) -
Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018) -
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)